Science
Mechanism of Action
This extract precisely targets and modulates key cellular pathways implicated in inflammation and oxidative stress. It primarily inhibits the MAPK (Mitogen Activated Protein Kinase) signaling pathways, thereby suppressing the production of pro-inflammatory cytokines (such as IL-1β) and chemokines in keratinocytes, which contributes to its ameliorative effects in conditions mimicking atopic dermatitis. Furthermore, it functions as a potent antioxidant by scavenging intracellular Reactive Oxygen Species (ROS) and preventing ERK phosphorylation, offering protection against environmental aggressors like Bisphenol A (BPA). Its mechanism also involves attenuating inflammatory responses and preventing dermal fibroblastic pyroptosis by suppressing the redox-sensitive transcription factor NF-κB and blocking inflammasome-mediated caspase-1 activation. Its efficacy is fortified by bioactive components including naringin, hesperidin, chlorogenic acid, and kaempferol.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 Demonstrated a reduction in the production of pro-inflammatory cytokines and chemokines, specifically IL-1β mRNA, in an in vitro atopic dermatitis mimic model using TNF-α/IFN-γ-stimulated HaCaT cells.
- 02 Further confirmed the reduction of pro-inflammatory cytokines and chemokines, including IL-1β mRNA, in the same in vitro atopic dermatitis mimic model.
- 03 Effectively decreased cytotoxicity and inhibited IL-1β mRNA expression and secretion induced by Bisphenol A (BPA) in normal human dermal fibroblasts (NHDFs). Additionally, it inhibited intracellular Reactive Oxygen Species (ROS) production and ERK phosphorylation.
Transparency
Dusting Analysis
Based on the provided data, there is no indication that GRIFOLIA FRONDOSA MYCELIUM FERMENT FILTRATE EXTRACT is commonly used at concentrations insufficient for efficacy or primarily for marketing claims.
The Formula
Formulation
Safety
Safety Profile
Specific safety evaluations, including dermal toxicity or sensitization data, for 'GRIFOLIA FRONDOSA MYCELIUM FERMENT FILTRATE EXTRACT' are not available. However, general 'Grifola frondosa' (Maitake mushroom) extracts such as D-fraction and MD-fraction have typically been reported as safe with low or negligible toxicity.
Your Skin
Skin Compatibility
Our Assessment
Verdict
GRIFOLIA FRONDOSA MYCELIUM FERMENT FILTRATE EXTRACT is a valuable ingredient, exhibiting compelling anti-inflammatory and antioxidant efficacy in vitro, making it well-suited for addressing skin sensitivity, environmental damage, and age-related concerns across all skin types.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources